OrganizationsAprinnova

Products 1 to 2 of 2

Neossance Hemisqualane by Aprinnova
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Japan + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Neossance Squalane by Aprinnova
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: Australia + Canada + China + Europe + Japan + Korea + Mexico + New Zealand + Philippines + Russia + USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product